C646 exerts protective effects against colitisinduced by DSS by inhibiting the activation of the NLRP3 inflammasomeand the NF-κB signaling pathway.C646 may be a candidate drug for the treatment of inflammatory boweldisease. This evidence concerns the gene NLRP3 and inflammatory bowel disease.